What is GLP-1 (Glucagon-Like Peptide-1)
STAT3 upregulates the protein expression and transcriptional activity of beta-catenin in breast cancer
Clinical studies show users of the medications can lose between 5% and 20% of their body weight on the medications over time
With these positive data in hand, we are moving with urgency toward global regulatory submissions to potentially meet the needs of patients who are waiting, said Kenneth Custer, executive vice president of Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company
Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients
Studies have shown that even after stopping treatment, most participants could sustain their weight loss